single-subject-design

A single-subject design evaluates behavior change within one participant by using structured phases like reversal or multiple baseline. It provides a rigorous framework for demonstrating experimental control and replication in both clinical and research contexts.

Implementing an A-B-A-B reversal design requires structuring alternating baseline and intervention phases to measure behavior change. This single-subject approach demonstrates functional relationships between the intervention and the target behavior for program evaluation and outcome measurement.

Yes, single-subject designs are applicable in clinical practice for functional behavior assessment (FBA) evaluations. They support ethical data-driven decision-making by enabling continuous visual analysis of phase-level data to evaluate treatment efficacy across diverse participants and settings.

Multiple baseline designs stagger intervention introduction across behaviors or participants, while alternating treatments designs rapidly alternate conditions. Both single-subject methods establish experimental control but differ in sequencing and practical application for behavior-analytic evaluation.

Single-subject designs may be unsuitable when experimental control cannot be demonstrated through phase reversals or staggered baselines due to ethical constraints. If target behaviors are irreversible or require group-level statistical analysis, alternative evaluation methods are necessary.